Use of Mechanical Circulatory Support in Patients with Non-Ischaemic Cardiogenic Shock

Abstract

In patients with non-ischaemic CS, MCS use was associated with lower 30-day mortality as compared to medical therapy only, but also with more complications. Randomized trials are needed to validate these findings.